Company Filing History:
Years Active: 2024
Title: Innovator Spotlight: Daniel Cua and His P116 Antibodies Patent
Introduction: Daniel Cua, a notable inventor based in Boulder Creek, California, has made significant contributions to the field of biomedical research. With one patent to his name, he represents the cutting-edge of innovation in antibody development.
Latest Patents: Cua's most recent patent concerns P116 antibodies. This invention provides antibodies and antigen-binding fragments that bind to PI16, an important target, and prevent the binding of ILT3 to PI16. This breakthrough has potential implications for therapeutic applications in the medical industry.
Career Highlights: Daniel Cua is currently employed at Merck Sharp & Dohme Corp., a leading pharmaceutical company renowned for its research and development in healthcare solutions. His expertise in the field has contributed to the company's strong portfolio of innovative products.
Collaborations: Throughout his career, Cua has collaborated with esteemed colleagues, including Holly Cherwinski and Adele Wang. Their joint efforts exemplify the spirit of teamwork that drives progress in scientific research and innovation.
Conclusion: Daniel Cua stands out in the realm of inventors with his impactful work on P116 antibodies. As a key player at Merck Sharp & Dohme Corp., his contributions not only enhance the company's reputation but also advance the field of antibody therapeutics. Cua's innovative spirit continues to inspire new breakthroughs in biomedical research.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.